The US stock market finished session lower on Friday, 29 January 2021, as risk aversion selloff triggered in reaction to news that Johnson & Johnson's (JNJ) one-dose coronavirus vaccine appears to be less potent against variants. Meanwhile, the sell-off partly reflected concerns about recent market volatility after Robinhood eased restrictions on certain stocks that have skyrocketed in recent trading.
At the close of trade, the Dow Jones Industrial Average index declined 620.74 points, or 2.03%, to 29,982.62. The S&P 500 index dropped 73.14 points, or 1.93%, to 3,714.24. The tech-heavy Nasdaq Composite Index shrank 266.46 points, or 2%, to 13,070.70.
For the week, the Dow closed 3.2% lower, the S&P 500 down 3.3% and Nasdaq Composite off 3.5%. On a monthly basis, the Dow lost 2%, the S&P 500 shed 1.1% and the Nasdaq Composite gained 1.7%.
Johnson & Johnson fell 3.6% as one of the biggest weights on both the Dow and S&P500 after the drugmaker said its single-dose vaccine was 72% effective in preventing COVID-19 in the United States, with a lower rate of 66% observed globally.
ECONOMIC NEWS: US Pending home Sales Slip By 0.3% In December--US pending home sales index slipped by 0.3 percent to 125.5 in December after tumbling by 2.5 percent to 125.9 in November, a report released by the National Association of Realtors on Friday showed. Pending home sales decreased for the fourth consecutive month but were still up by 21.4 percent compared to the same month a year ago. A pending home sale is one in which a contract was signed but not yet closed. Normally, it takes four to six weeks to close a contracted sale.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU